• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

DOD PROSTATE: Prostate Cancer Patients Should Heed Cardiovascular Risk Factors

Article

ATLANTA -- A prostate cancer diagnosis should be a cardiovascular wake-up call, said researchers here.

ATLANTA, Sept. 12 -- An early prostate cancer diagnosis should be a cardiovascular wake-up call, said researchers here.

Whether prostate cancer patients are treated with expectant management or definitive treatment, they are more likely to die of non-prostate cancer causes, particularly cardiovascular, said Stephen Freedland, M.D., an assistant professor of urology and pathology at Duke.

"When people hear they have prostate cancer, all their concentration and energy is focused on the cancer," he said at a symposium sponsored by the Department of Defense Prostate Cancer Research Program.

Yet Dr. Freedland noted that 170 out of 100,000 men who are diagnosed with prostate cancer. But, he added, just 32 of those 170 men actually die of prostate cancer. The other 138 men die of something else -- and usually that is cardiovascular disease.

"Non-prostate cancer mortality remains the greatest threat to overall health," said Dr. Freedland. "While all prostate cancer treatments can worsen quality of life, particularly sexual function, dietary and lifestyle interventions can actually improve overall quality of life and have been shown to improve erectile function."

"Given that dietary and lifestyle interventions are known to reduce the risk of heart disease, these therapies for men with low-risk disease are likely to have a greater impact on improving overall survival than any prostate cancer related treatment," he said.

He noted that many patients when told they have prostate cancer, but have opted for expectant management are uncomfortable about doing nothing. "By including dietary and lifestyle modification as part of their treatment, the patient will have an active role in improving his health," Dr. Freedland said. He also said there are studies that indicate weight loss, exercise and dietary changes may improve the course of the cancer itself.

"It is unlikely that such changes will be bad for course of the cancer, and there is a chance that it will be good," he said.

He said that he tells his patients who have elected to undergo expectant management -- and even those who have curative treatment, that they should attempt to lose weight, reduce saturated fat intake, reduce intake of refined carbohydrates, exercise more and stop smoking.

"Men diagnosed with prostate cancer should work on improving their cardiovascular health because more men with prostate cancer will die of heart attacks and strokes than of their cancer," noted Capt. E. Melissa Kaime, M.D., of the U.S. Navy Medical Corps, and deputy director of the Congressionally Directed Medical Research Programs.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
"Obesity is a Medically Approachable Problem" and Other Lessons with Lee Kaplan, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.